UA111594C2 - Гетероциклічна сполука і її застосування - Google Patents

Гетероциклічна сполука і її застосування

Info

Publication number
UA111594C2
UA111594C2 UAA201302884A UAA201302884A UA111594C2 UA 111594 C2 UA111594 C2 UA 111594C2 UA A201302884 A UAA201302884 A UA A201302884A UA A201302884 A UAA201302884 A UA A201302884A UA 111594 C2 UA111594 C2 UA 111594C2
Authority
UA
Ukraine
Prior art keywords
applications
heterocyclic compound
compound
potentiator
ampa
Prior art date
Application number
UAA201302884A
Other languages
English (en)
Inventor
Масакуні Корі
Тошіхіро Імаєда
Шінджі Накамура
Масаші Тойофуку
Еіджі Хонда
Ясутомі Асано
Осаму Уджікава
Мічійо Мочізукі
Original Assignee
Такеда Фармасьютікал Компані Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Фармасьютікал Компані Лімітед filed Critical Такеда Фармасьютікал Компані Лімітед
Publication of UA111594C2 publication Critical patent/UA111594C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Описується сполука, представлена формулою (І):, (I)де кожен символ є таким, як визначено в описі, або її сіль, яка є потенціатором рецептора АМРА (α-аміно-3-гідрокси-5-метил-4-ізоксазолпропіонова кислота). Сполука представленого винаходу корисна як профілактичний або терапевтичний лікарський засіб для депресії, шизофренії, хвороби Альцгеймера або гіперактивності з дефіцитом уваги (ADHD) і т. і.
UAA201302884A 2010-08-10 2011-09-08 Гетероциклічна сполука і її застосування UA111594C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Publications (1)

Publication Number Publication Date
UA111594C2 true UA111594C2 (uk) 2016-05-25

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201302884A UA111594C2 (uk) 2010-08-10 2011-09-08 Гетероциклічна сполука і її застосування

Country Status (38)

Country Link
US (10) US8575154B2 (uk)
EP (1) EP2603513B1 (uk)
JP (2) JP5788496B2 (uk)
KR (1) KR101852215B1 (uk)
CN (2) CN104926837A (uk)
AR (1) AR082618A1 (uk)
AU (1) AU2011290126B2 (uk)
BR (1) BR112013002250B1 (uk)
CA (1) CA2807460C (uk)
CL (1) CL2013000380A1 (uk)
CO (1) CO6680700A2 (uk)
CR (1) CR20130066A (uk)
CY (1) CY1123507T1 (uk)
DK (1) DK2603513T3 (uk)
DO (1) DOP2013000030A (uk)
EA (1) EA022078B1 (uk)
EC (1) ECSP13012478A (uk)
ES (1) ES2793723T3 (uk)
GE (1) GEP20156216B (uk)
HR (1) HRP20200844T1 (uk)
HU (1) HUE049460T2 (uk)
IL (1) IL224452A (uk)
LT (1) LT2603513T (uk)
MA (1) MA34509B1 (uk)
MX (1) MX349470B (uk)
MY (1) MY165908A (uk)
NZ (1) NZ607593A (uk)
PE (1) PE20131116A1 (uk)
PL (1) PL2603513T3 (uk)
PT (1) PT2603513T (uk)
RS (1) RS60311B1 (uk)
SG (1) SG187656A1 (uk)
SI (1) SI2603513T1 (uk)
TW (1) TWI504604B (uk)
UA (1) UA111594C2 (uk)
UY (1) UY33551A (uk)
WO (1) WO2012020848A1 (uk)
ZA (1) ZA201301120B (uk)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20131116A1 (es) * 2010-08-10 2013-10-24 Takeda Pharmaceutical Compuestos heterociclicos potenciadores de ampa
EP2694472B1 (en) * 2011-04-05 2020-03-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
US9493484B2 (en) 2012-02-08 2016-11-15 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
CA2915405A1 (en) * 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders
DK3013813T3 (da) 2013-06-27 2019-06-03 Pfizer Heteroaromatiske forbindelser og anvendelse deraf som dopamin-d1-ligander
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
EP3663282B1 (en) 2013-12-03 2022-05-18 FMC Corporation Pyrrolidinone herbicides
EP3164386B1 (en) 2014-07-02 2020-10-07 FMC Corporation Piperidinone herbicides
CN107001260B (zh) 2014-12-08 2020-11-10 Fmc公司 3-氧基-3-(芳氨基)丙酸酯、其制备方法、以及其在制备吡咯烷酮中的用途
AU2016246410B2 (en) 2015-04-10 2020-11-05 Fmc Corporation Substituted cyclic amides as herbicides
CN107531658B (zh) 2015-04-27 2021-07-27 Fmc公司 作为除草剂的丁内酯
UY36654A (es) * 2015-04-29 2016-10-31 Janssen Pharmaceutica Nv Azabenzimidazoles con propiedades moduladoras del receptor ampa y composiciones farmacéuticas que los contienen
WO2016176457A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
BR112017021859B1 (pt) 2015-05-12 2022-05-10 Fmc Corporation Composto, composições herbicidas, mistura herbicida e método para o controle do crescimento de vegetação indesejada
JP6869192B2 (ja) 2015-05-29 2021-05-12 エフ エム シー コーポレーションFmc Corporation 除草剤としての置換環状アミド
CA2983759A1 (en) 2015-06-02 2016-12-08 E I Du Pont De Nemours And Company Substituted cyclic amides and their use as herbicides
EP3328836B1 (en) 2015-07-31 2021-03-24 FMC Corporation Cyclic n-carboxamide compounds useful as herbicides
TW201713774A (zh) 2015-08-06 2017-04-16 Kohjin Life Sciences Co Ltd 含有β-菸鹼醯胺單核苷酸的酵母萃取物及其製造方法
KR102579520B1 (ko) * 2015-08-06 2023-09-15 에프. 호프만-라 로슈 아게 Galnac 산 유도체의 제조 방법
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
ES2958741T3 (es) 2016-12-21 2024-02-14 Fmc Corp Herbicidas de nitrona
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
AU2018239935B2 (en) 2017-03-21 2023-05-18 Fmc Corporation Pyrrolidinones and a process to prepare them
EP3599868A4 (en) 2017-03-21 2020-12-02 FMC Corporation HERBICIDE MIXTURE, COMPOSITION AND PROCEDURE
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
ES2971497T3 (es) 2017-10-06 2024-06-05 Takeda Pharmaceuticals Co Compuestos heterocíclicos
EP3693368B1 (en) * 2017-10-06 2023-12-06 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2021229294A1 (en) 2020-05-15 2021-11-18 Takeda Pharmaceutical Company Limited Treatment for depression

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (uk) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
JP2003526341A (ja) 1999-11-04 2003-09-09 コロラド ステート ユニバーシティー リサーチ ファウンデーション 昆虫を誘引するための装置および方法
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1275951C (zh) * 2001-10-10 2006-09-20 神经研究公司 新的苯并噻嗪衍生物、其制备和应用
FR2833955B1 (fr) 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2007262661A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
EA015600B1 (ru) * 2006-12-11 2011-10-31 Эли Лилли Энд Компани Агенты, усиливающие действие амра-рецепторов
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
WO2009061699A1 (en) * 2007-11-05 2009-05-14 Schering Corporation Gamma secretase modulators
JP2011507910A (ja) 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
US20110118236A1 (en) 2008-03-25 2011-05-19 Michiyo Mochizuki Heterocyclic compound
JP2009248543A (ja) 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
US20120129846A1 (en) 2008-11-06 2012-05-24 Zhaoning Zhu Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
EP2455380A4 (en) 2009-07-13 2012-11-28 Takeda Pharmaceutical Heterocyclic compound and its use
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
PE20131116A1 (es) * 2010-08-10 2013-10-24 Takeda Pharmaceutical Compuestos heterociclicos potenciadores de ampa

Also Published As

Publication number Publication date
US8778934B2 (en) 2014-07-15
EA201390222A1 (ru) 2013-08-30
US10654874B2 (en) 2020-05-19
JP5788496B2 (ja) 2015-09-30
SI2603513T1 (sl) 2020-07-31
MX349470B (es) 2017-07-31
WO2012020848A1 (en) 2012-02-16
CN103180326B (zh) 2015-06-10
HRP20200844T1 (hr) 2020-08-21
US20150073137A1 (en) 2015-03-12
AU2011290126A1 (en) 2013-03-07
DK2603513T3 (da) 2020-06-15
KR20130138738A (ko) 2013-12-19
CN104926837A (zh) 2015-09-23
BR112013002250A2 (pt) 2016-05-24
ES2793723T3 (es) 2020-11-16
CY1123507T1 (el) 2022-03-24
NZ607593A (en) 2015-01-30
PT2603513T (pt) 2020-06-08
AU2011290126B2 (en) 2016-01-07
US20130190291A1 (en) 2013-07-25
US20140080817A1 (en) 2014-03-20
UY33551A (es) 2012-03-30
MX2013001614A (es) 2013-07-05
EP2603513B1 (en) 2020-03-11
LT2603513T (lt) 2020-05-25
US8916551B2 (en) 2014-12-23
US20130184266A1 (en) 2013-07-18
JP2013535408A (ja) 2013-09-12
US20190263832A1 (en) 2019-08-29
MY165908A (en) 2018-05-18
JP2016006080A (ja) 2016-01-14
EA022078B1 (ru) 2015-10-30
ECSP13012478A (es) 2013-04-30
AR082618A1 (es) 2012-12-19
CL2013000380A1 (es) 2013-05-31
CA2807460A1 (en) 2012-02-16
PE20131116A1 (es) 2013-10-24
JP6113789B2 (ja) 2017-04-12
US8575154B2 (en) 2013-11-05
SG187656A1 (en) 2013-03-28
US9150591B2 (en) 2015-10-06
BR112013002250B1 (pt) 2020-10-27
US20120077799A1 (en) 2012-03-29
HUE049460T2 (hu) 2020-09-28
MA34509B1 (fr) 2013-09-02
KR101852215B1 (ko) 2018-04-25
CN103180326A (zh) 2013-06-26
CA2807460C (en) 2018-09-18
RS60311B1 (sr) 2020-07-31
US20180162875A1 (en) 2018-06-14
US11279713B2 (en) 2022-03-22
US9884875B2 (en) 2018-02-06
US9499568B2 (en) 2016-11-22
DOP2013000030A (es) 2013-03-15
TW201217386A (en) 2012-05-01
US20170022222A1 (en) 2017-01-26
CO6680700A2 (es) 2013-05-31
IL224452A (en) 2017-11-30
CR20130066A (es) 2013-05-03
TWI504604B (zh) 2015-10-21
ZA201301120B (en) 2014-04-30
PL2603513T3 (pl) 2020-07-27
WO2012020848A8 (en) 2012-09-27
US20150353578A1 (en) 2015-12-10
GEP20156216B (en) 2015-01-12
EP2603513A1 (en) 2013-06-19
US20200317692A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
UA111594C2 (uk) Гетероциклічна сполука і її застосування
WO2012137982A3 (en) Sulfonamide derivative and use thereof
CY1121549T1 (el) Ενωσεις 1-αρυλκαρβονυλ-4-oξυ-πιπεριδινης χρησιμες για την αγωγη νευροεκφυλιστικων παθησεων
UA113051C2 (xx) Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
BR112015000399A2 (pt) derivados de pirazolil pirimidina
MA33939B1 (fr) 5-alcynyl-pyrimidines
MX2011005934A (es) Compuestos organicos.
BR112012033350A2 (pt) "composição e métodos para modular a via de sinalização de wnt"
BR112012010186A2 (pt) derivados de heteroarila contendo n como inibidores de quinase jak3.
CO6821935A2 (es) Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos
BR112014005468A2 (pt) derivados de aminopiridina para uso como moduladores de atividade quinase
BR112012029647A2 (pt) novos derivados de pirimidinas
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
EA201200471A1 (ru) Простые эфирные производные бициклических гетероарилов
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
DE602007008691D1 (de) Cyclische sulfone, die zur verwendung als bace-inhibitoren geeignet sind
EA201170606A1 (ru) Феназопиридиновые соединения
TN2013000034A1 (en) Heterocyclic compound and use thereof
NI201200039A (es) Nuevos derivados dihidro - oxazolobenzodiazepinonas, su procedi
MX2013006185A (es) Compuestos de 6-(piridinilmetoxi) -pirrolopiridina 3-sustituidos.